In vitro effects of combined and sequential bone morphogenetic protein administration

Archives of Facial Plastic Surgery

Volumn 9, Issue 4, 2007, Pages 242-247

  Arosarena, Oneida A ^a   Puleo, David ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; RUNX2 PROTEIN, MOUSE; SMAD1 PROTEIN; SMAD1 PROTEIN, MOUSE; SMAD5 PROTEIN; SMAD5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BONE MINERALIZATION; CRANIOFACIAL MALFORMATION; DNA REPLICATION; DRUG EFFECT; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; MOUSE; OSTEOBLAST;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIOFACIAL ABNORMALITIES; DNA REPLICATION; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MICE; OSTEOBLASTS; OSTEOCALCIN; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 34547428613     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.9.4.242     Document Type: Article

References (27)

1. Giannobile WV. Periodontal tissue engineering by growth factors. Bone. 1996;19 (1 suppl):23S-37S.
2. Hing KA. Bone repair in the twenty-first century: biology, chemistry, or engineering? Philos Transact A Math Phys Eng Sci. 1825;2004(362):2821- 2850.
3. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering; state of the art and future trends. Macromol Biosci. 2004;4(8):743-765.
4. Howell TH, Fiorellini JP, Paquette DW. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol. 1997;68(12):1186-1193.
5. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants: results of a pilot study in beagle dogs. J Periodontol. 1991;62(11):710-716.
6. Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials. 2004;25(4):677-685.
7. Takita H, Tsuruga E, Ono I, Kuboki Y. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats, Eur J Oral Sci. 1997;105(6):588-592.
8. Yeh LC, Zavala MC, Lee JC. Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. J Cell Physiol. 2002;190(3):322-331.
9. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110(6):751-759.
10. De Groot J. Carriers that concentrate native bone morphogenetic protein in vivo. Tissue Eng.1998;4(4):337-341.
11. Ripamonti U, Crooks J, Petit JC, Rueger DC. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2: a pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci. 2001;109(4):241-248.
12. Vonau RL, Bostrom MP, Aspenberg P, Sams AE. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res. 2001;386(386):243-251.
13. Spector JA, Luchs JS, Mehrara BJ, Greenwald JA, Smith LP, Longaker MT. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg. 2001;107(1):124-134.
14. Campisi P, Hamdy RC, Lauzier D, Amako M, Rauch F, Lessard ML. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg. 2003;111(1):209-210.
15. Campisi P, Hamdy RC, Lauzier D, Amako M, Schloss MD, Lessard ML. Overview of the radiology, histology, and bone morphogenetic protein expression during distraction osteogenesis of the mandible. J Otolaryngol. 2002;31(5):281-286.
16. Yazawa M, Kishi K, Nakajima H, Nakajima T. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis in rabbits. J Oral Maxillofac Surg. 2003;61(5):587-592.
17. Zhu W, Rawlins BA, Boachie-Adjei O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004;19(12):2021-2032.
18. Reddi AH. Bone morphogenetic proteins and skeletal development: the kidney-bone connection. Pediatr Nephrol. 2000;14(7):598-601.
19. Ikeda S, Hachisu R, Yamaguchi A, Gao YH, Okano T. Radiation retards muscle differentiation but does not affect osteoblastic differentiation induced by bone morphogenetic protein-2 in C2C12 myoblasts. Int J Radiat Biol. 2000;76(3):403-411.
20. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors. 1993;9(1):57-71.
21. Atkinson BL, Fantle KS, Benedict JJ, Huffer WE, Gutierrez-Hartmann A. Combination of osteoinductive bone proteins differentiates mesenchymal C3H/10T1/2 cells specifically to the cartilage lineage. J Cell Biochem. 1997;65(3):325-339.
22. Elder SH, Fulzele KS, McCulley WR. Cyclic hydrostatic compression stimulates cnondroinduction of C3H/10T1/2 cells. Biomech Model Mechanobiol. 2005;3(3):141-146.
23. Laitinen M, Halttunen T, Jortikka L, Teronen O, Sorsa T, Lindholm TS. The role of transforming growth factor-beta on retarded osteoblastic differentiation in vitro. Life Sci. 1999;64(10):847-858.
24. Strayhorn CL, Garrett JS, Dunn RL, Benedict JJ, Somerman MJ. Growth factors regulate expression of osteoblast-associated genes. J Periodontol. 1999;70(11):1345-1354.
25. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994;127(6 pt 1 ):1755-1766.
26. Lee MH, Javed A, Kim H, et al. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cell coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem. 1999;73(1):114-125.
27. Urist MR, DeLange RJ, Finerman GAM. Bone cell differentiation and growth factors. Science. 1983;220(4598):680-686.